Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Autolus Therapeutics Plc ADR (AUTL)

Autolus Therapeutics Plc ADR (AUTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Autolus Therapeutics Plc ADR THE MEDIAWORKS 191 WOOD LANE LONDON X0 W12 7FP GBR

www.autolus.com P: 44-20-3829-6230

Description:

Autolus Therapeutics plc is a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies. The company's pipeline of product candidate involved in development for the treatment of haematological malignancies and solid tumours. Autolus Therapeutics plc is based in London, United Kingdom.

Key Statistics

Overview:

Market Capitalization, $K 1,205,143
Enterprise Value, $K 964,803
Shares Outstanding, K 266,036
Annual Sales, $ 1,700 K
Annual Net Income, $ -208,380 K
Last Quarter Sales, $ 10,090 K
Last Quarter Net Income, $ -52,690 K
EBIT, $ -175,360 K
EBITDA, $ -168,790 K
60-Month Beta 2.02
% of Insider Shareholders 25.70%
% of Institutional Shareholders 72.83%
Float, K 197,665
% Float 74.30%
Short Volume Ratio 0.58

Growth:

1-Year Return 55.71%
3-Year Return -40.55%
5-Year Return -72.43%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 15.49%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.24 on 05/17/24
Next Earnings Date 08/01/24
Earnings Per Share ttm -1.20
EPS Growth vs. Prev Qtr 45.45%
EPS Growth vs. Prev Year -4.35%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

AUTL Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -80.21%
Return-on-Assets % -41.48%
Profit Margin % -12,257.65%
Debt/Equity 0.00
Price/Sales 679.97
Price/Cash Flow N/A
Price/Book 1.98
Book Value/Share 2.19
Interest Coverage -3.62
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar